Collecting duct (Bellini duct) renal cell carcinoma: a clinical case and literature review
N. I. Sorokin,
V. E. Sinitsyn,
O. A. Kharlova,
A. A. Strigunov,
O. Yu. Nesterova,
R. A. Nikoghosyan,
E. A. Galliamov,
A. A. Kamalov https://doi.org/10.21886/2308-6424-2024-12-2-108-119
Abstract
A rare subtype of renal cell carcinoma (RCC) is Bellini collecting duct carcinoma, also known as medullary renal carcinoma or distal nephron carcinoma, which accounts for 0.4-2.0% of all RCC cases. This subtype has the poorest prognosis of all RCC subtypes, typically presenting as a low-grade tumor at the pT3 or higher stage. Consequently, many patients have distant metastases at diagnosis and 60% develop metastases following radical treatment. There have been approximately 400 literature-reported cases of Bellini ductal carcinoma to date. We present a case report of a patient with early-stage Bellini duct cancer and a literature review of published reports on this condition.
About the Authors
N. I. Sorokin
Lomonosov Moscow State University (Lomonosov University)
Russian Federation
Competing Interests:
Russian Federation
Nikolay I. Sorokin — M.D., Dr.Sc.(Med), Full. Prof.; Prof., Dept. of Urology and Andrology, Faculty of Fundamental Medicine; Leading Researcher, Urology and Andrology Research Unit, Medical Research and Education Centre, Lomonosov Moscow State University
Moscow
Competing Interests:
The authors declare no conflicts of interest.
V. E. Sinitsyn
Lomonosov Moscow State University (Lomonosov University)
Russian Federation
Competing Interests:
Russian Federation
Valentin E. Sinitsyn — Dr.Sc.(Med), Full Prof., Head, Dept. of Radiology, Faculty of Fundamental Medicine
Moscow
Competing Interests:
The authors declare no conflicts of interest.
O. A. Kharlova
Lomonosov Moscow State University (Lomonosov University)
Russian Federation
Competing Interests:
Russian Federation
Olga A. Kharlova — M.D., Cand. Sc. (Med); Researcher, Clinical Pathology Unit, Medical Research and Educational Centre
Moscow
Competing Interests:
The authors declare no conflicts of interest.
A. A. Strigunov
Lomonosov Moscow State University (Lomonosov University)
Russian Federation
Competing Interests:
Russian Federation
Andrey A. Strigunov — M.D.; Urologist – General Clinical Division, Trainee Researcher – Urology and Andrology Unit, Medical Research and Education Centre; Postgrad. Student, Dept. of Urology and Andrology, Faculty of Fundamental Medicine, Lomonosov Moscow State University
Moscow
Competing Interests:
The authors declare no conflicts of interest.
O. Yu. Nesterova
Lomonosov Moscow State University (Lomonosov University)
Russian Federation
Competing Interests:
Russian Federation
Olga Yu. Nesterova — M.D., Сand.Sc.(Med); Urologist – General Clinical Division, Researcher – Urology and Andrology Unit, Medical Research and Education Centre; Senior Lecturer, Dept. of Urology and Andrology, Faculty of Fundamental Medicine, Lomonosov Moscow State University
Moscow
Competing Interests:
The authors declare no conflicts of interest.
R. A. Nikoghosyan
Lomonosov Moscow State University (Lomonosov University)
Russian Federation
Competing Interests:
Russian Federation
Ruzanna A. Nikoghosyan — M.D.; Radiologist, Postgrad. student, Dept. of Radiology, Faculty of Fundamental Medicine
Moscow
Competing Interests:
The authors declare no conflicts of interest.
E. A. Galliamov
Lomonosov Moscow State University (Lomonosov University)
Russian Federation
Competing Interests:
Russian Federation
Eduard A. Galliamov — M.D., Dr.Sc.(Med), Full Prof., Leading Researcher, Surgery and Oncology Unit, Medical Research and Education Centre
Moscow
Competing Interests:
The authors declare no conflicts of interest.
A. A. Kamalov
Lomonosov Moscow State University (Lomonosov University)
Russian Federation
Competing Interests:
Russian Federation
Armais A. Kamalov — MD, Dr.Sc.(Med), Full Prof., Academician of the RAS; Director, Medical Research and Education Centre, Lomonosov Moscow State University; Head, Dept. of Urology and Andrology, Faculty of Medicine, Lomonosov Moscow State University
Moscow
Competing Interests:
The authors declare no conflicts of interest.
References
1. Andreeva Yu.Yu., Danilova N.V., Moskvina L.V., Zavalishina L.E., Kekeeva T.V., Mal'kov P.G., Frank G.A. Tumors of the urinary system and male genitalia. Morphological diagnostics and genetics: A guide for doctors. Moscow: Practical medicine; 2012. (In Russian).
2. Sui W, Matulay JT, Robins DJ, James MB, Onyeji IC, Roy-Choudhury A, Wenske S, DeCastro GJ. Collecting duct carcinoma of the kidney: Disease characteristics and treatment outcomes from the National Cancer Database. Urol Oncol. 2017;35(9):540.e13-540.e18. DOI: 10.1016/j.urolonc.2017.04.010
3. Tang C, Zhou Y, Ge S, Yi X, Lv H, Zhou W. Incidence, Clinical Characteristics, and Survival of Collecting Duct Carcinoma of the Kidney: A Population-Based Study. Front Oncol. 2021;11:727222. DOI: 10.3389/fonc.2021.727222
4. Cromie WJ, Davis CJ, DeTure FA. Atypical carcinoma of kidney: possibly originating from collecting duct epithelium. Urology. 1979;13(3):315-317. DOI: 10.1016/0090-4295(79)90434-5
5. Fleming S, Lewi HJ. Collecting duct carcinoma of the kidney. Histopathology. 1986;10(11):1131-1141. DOI: 10.1111/j.1365-2559.1986.tb02553.x
6. Karakiewicz PI, Trinh QD, Rioux-Leclercq N, de la Taille A, Novara G, Tostain J, Cindolo L, Ficarra V, Artibani W, Schips L, Zigeuner R, Mulders PF, Lechevallier E, Coulange C, Valeri A, Descotes JL, Rambeaud JJ, Abbou CC, Lang H, Jacqmin D, Mejean A, Patard JJ. Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol. 2007;52(4):1140-1145. DOI: 10.1016/j.eururo.2007.01.070
7. Tokuda N, Naito S, Matsuzaki O, Nagashima Y, Ozono S, Igarashi T; Japanese Society of Renal Cancer. Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. J Urol. 2006;176(1):40-43; discussion 43. DOI: 10.1016/S0022-5347(06)00502-7
8. Cabanillas G, Montoya-Cerrillo D, Kryvenko ON, Pal SK, Arias-Stella JA 3rd. Collecting duct carcinoma of the kidney: diagnosis and implications for management. Urol Oncol. 2022;40(12):525-536. DOI: 10.1016/j.urolonc.2021.04.041
9. Yin M, Wang W, Rosenberg J, Kaag M, Joshi M, Holder S, Tuanquin L, Drabick JJ. Targeted Therapy in Collecting Duct Carcinoma of the Kidney: A Case Report and Literature Review. Clin Genitourin Cancer. 2016;14(2):e203-e206. DOI: 10.1016/j.clgc.2015.11.008
10. Ciszewski S, Jakimów A, Smolska-Ciszewska B. Collecting (Bellini) duct carcinoma: A clinical study of a rare tumour and review of the literature. Can Urol Assoc J. 2015;9(9-10):E589-E593. DOI: 10.5489/cuaj.2932
11. Singh I, Nabi G. Bellini duct carcinoma: review of diagnosis and management. Int Urol Nephrol. 2002;34(1):91-95. DOI: 10.1023/a:1021315130481
12. Zhou JX, He XR, Song GX, Zou ZG, Wang LH, Hu R, Li HX. [Clinicopathologic features with collecting duct carcinoma of kidney: report of 10 cases]. Zhonghua Bing Li Xue Za Zhi. 2018;47(2):123-127. (In Chinese) DOI: 10.3760/cma.j.issn.0529-5807.2018.02.009
13. Chen J, Cai D, Gong K, Zhu S. Collecting Duct Carcinoma of the Kidney: Analysis of 74 Cases From Multiple Centers. Urology. 2022;164:163-168. DOI: 10.1016/j.urology.2022.01.032
14. Pickhardt PJ, Siegel CL, McLarney JK. Collecting duct carcinoma of the kidney: are imaging findings suggestive of the diagnosis? AJR Am J Roentgenol. 2001;176(3):627-633. DOI: 10.2214/ajr.176.3.1760627
15. Wang L, Peng L, Hou T, Shi Y. Renal collecting duct carcinoma: report of a case with unusual imaging findings regarding renal function. J Cancer Res Ther. 2013;9(2):331-333. DOI: 10.4103/0973-1482.113425
16. Vanderbruggen W, Claessens M, De Coninck V, Duchateau A, Gevaert T, Joniau S, Hente R. Collecting duct renal cell carcinoma: a single centre series and review of the literature. Cent European J Urol. 2022;75(3):252-256. DOI: 10.5173/ceju.2022.0143
17. Xie Z, Yadav S, Lohse CM, Cheville JC, Pagliaro LC, Shah PH, Boorjian SA, Thompson H, Leibovich BC, Costello BA. Collecting duct carcinoma: A single-institution retrospective study. Urol Oncol. 2022;40(1):13.e9-13.e18. DOI: 10.1016/j.urolonc.2021.09.019
18. Pal SK, Choueiri TK, Wang K, Khaira D, Karam JA, Van Allen E, Palma NA, Stein MN, Johnson A, Squillace R, Elvin JA, Chmielecki J, Yelensky R, Yakirevich E, Lipson D, Lin DI, Miller VA, Stephens PJ, Ali SM, Ross JS. Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling. Eur Urol. 2016;70(3):516-521. DOI: 10.1016/j.eururo.2015.06.019
19. Wang J, Papanicolau-Sengos A, Chintala S, Wei L, Liu B, Hu Q, Miles KM, Conroy JM, Glenn ST, Costantini M, Magi-Galluzzi C, Signoretti S, Choueiri T, Gallucci M, Sentinelli S, Fazio VM, Poeta ML, Liu S, Morrison C, Pili R. Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation. Oncotarget. 2016;7(21):29901-29915. DOI: 10.18632/oncotarget.9093
20. Qian X, Wang Z, Zhang J, Wang Q, Zhou P, Wang S, Wang B, Qian C. Clinical Features and Prognostic Outcome of Renal Collecting Duct Carcinoma: 12 Cases from a Single Institution. Cancer Manag Res. 2020;12:3589-3595. DOI: 10.2147/CMAR.S244094
21. Gollob JA, Upton MP, DeWolf WC, Atkins MB. Long-term remission in a patient with metastatic collecting duct carcinoma treated with taxol/carboplatin and surgery. Urology. 2001;58(6):1058. DOI: 10.1016/s0090-4295(01)01411-x
22. Oudard S, Banu E, Vieillefond A, Fournier L, Priou F, Medioni J, Banu A, Duclos B, Rolland F, Escudier B, Arakelyan N, Culine S; GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales). Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study. J Urol. 2007;177(5):1698-1702. DOI: 10.1016/j.juro.2007.01.063
23. Rizzo M, Chiellino S, Gernone A, Porta C. Cisplatin-based chemotherapy for the treatment of metastatic collecting duct carcinomas: A real-world, retrospective analysis. Front Oncol. 2022;12:939953. DOI: 10.3389/fonc.2022.939953
24. Houmaidi AE, Aynaou M, Mhanna T, Dua Boating P, Chennoufi M, Barki A. A huge collecting duct carcinoma of the kidney in an elderly woman: Diagnosis and managment challenge (uncommon condition). Urol Case Rep. 2020;33:101375. DOI: 10.1016/j.eucr.2020.101375
25. Chao D, Zisman A, Pantuck AJ, Gitlitz BJ, Freedland SJ, Said JW, Figlin RA, Belldegrun AS. Collecting duct renal cell carcinoma: clinical study of a rare tumor. J Urol. 2002;167(1):71-74. DOI: 10.1016/s0022-5347(05)65385-2
26. Fuu T, Iijima K, Kusama Y, Otsuki T, Kato H. Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report. J Med Case Rep. 2022;16(1):193. DOI: 10.1186/s13256-022-03426-3
27. Xiao R, Liu C, He W, Ma L. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma. Biomed Res Int. 2021;2021:6736008. DOI: 10.1155/2021/6736008
Review
For citations:
Sorokin N.I., Sinitsyn V.E., Kharlova O.A., Strigunov A.A., Nesterova O.Yu., Nikoghosyan R.A., Galliamov E.A., Kamalov A.A. Collecting duct (Bellini duct) renal cell carcinoma: a clinical case and literature review. Urology Herald. 2024;12(2):108-119. (In Russ.) https://doi.org/10.21886/2308-6424-2024-12-2-108-119
Views:
1687
Email this article 
